The microtubule-affecting drug paclitaxel has antiangiogenic activity. D Belotti, V Vergani, T Drudis, P Borsotti, MR Pitelli, G Viale, R Giavazzi, ... Clinical Cancer Research 2 (11), 1843-1849, 1996 | 827 | 1996 |
Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells G Taraboletti, S D'Ascenzo, P Borsotti, R Giavazzi, A Pavan, V Dolo The American journal of pathology 160 (2), 673-680, 2002 | 755 | 2002 |
Shedding of MMP-2, MMP-9 and MT1-MMP as membrane vesicle-associated components by endothelial cells G Taraboletti, S D'Ascenzo, P Borsotti, R Giavazzi, A Pavan, V Dolo | 755* | 2002 |
Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice S Naito, AC von Eschenbach, R Giavazzi, IJ Fidler Cancer research 46 (8), 4109-4115, 1986 | 585 | 1986 |
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. G Taraboletti, D Roberts, LA Liotta, R Giavazzi The Journal of cell biology 111 (2), 765-772, 1990 | 535 | 1990 |
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation D Belotti, P Paganoni, L Manenti, A Garofalo, S Marchini, G Taraboletti, ... Cancer research 63 (17), 5224-5229, 2003 | 476 | 2003 |
Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization< i> In Vivo</i> D Salani, G Taraboletti, L Rosanò, V Di Castro, P Borsotti, R Giavazzi, ... The American journal of pathology 157 (5), 1703-1711, 2000 | 468 | 2000 |
Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice R Giavazzi, DE Campbell, JM Jessup, K Cleary, IJ Fidler Cancer Research 46 (4 Part 2), 1928-1933, 1986 | 324 | 1986 |
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases G Taraboletti, A Garofalo, D Belotti, T Drudis, P Borsotti, E Scanziani, ... JNCI: Journal of the National Cancer Institute 87 (4), 293-298, 1995 | 309 | 1995 |
Matrix metalloproteinase inhibition: a review of anti-tumour activity PD Brown, R Giavazzi Annals of Oncology 6 (10), 967-974, 1995 | 302 | 1995 |
Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. R Giavazzi, M Foppolo, R Dossi, A Remuzzi The Journal of clinical investigation 92 (6), 3038-3044, 1993 | 287 | 1993 |
Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice R Giavazzi, A Garofalo, MR Bani, M Abbate, P Ghezzi, D Boraschi, ... Cancer Research 50 (15), 4771-4775, 1990 | 267 | 1990 |
Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH G Taraboletti, S D'Ascenzoy, I Giusti, D Marchetti, P Borsotti, D Millimaggi, ... Neoplasia 8 (2), 96-103, 2006 | 260 | 2006 |
Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor RGS Chirvi, A Garofalo, MJ Crimmin, LJ Bawden, A Stoppacciaro, ... International journal of cancer 58 (3), 460-464, 1994 | 257 | 1994 |
Experimental nude mouse model of human colorectal cancer liver metastases R Giavazzi, JM Jessup, DE Campbell, SM Walker, IJ Fidler JNCI: Journal of the National Cancer Institute 77 (6), 1303-1308, 1986 | 229 | 1986 |
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis R Giavazzi, B Sennino, D Coltrini, A Garofalo, R Dossi, R Ronca, ... The American journal of pathology 162 (6), 1913-1926, 2003 | 220 | 2003 |
Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts. G Valoti, MI Nicoletti, A Pellegrino, J Jimeno, H Hendriks, M D'Incalci, ... Clinical cancer research 4 (8), 1977-1983, 1998 | 199 | 1998 |
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia … M Broggini, SV Marchini, E Galliera, P Borsotti, G Taraboletti, E Erba, ... Leukemia 17 (1), 52-59, 2003 | 189 | 2003 |
The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells G Taraboletti, L Morbidelli, S Donnini, A Parenti, HJ Granger, R Giavazzi, ... The FASEB Journal 14 (12), 1674-1676, 2000 | 189 | 2000 |
Transfer of the HSV-tk Gene into Donor Peripheral Blood Lymphocytes for In Vivo Modulation of Donor Anti-Tumor Immunity after Allogeneic Bone Marrow Transplantation. The San … C Bordignon, C Bonini, S Verzeletti, N Nobili, D Maggioni, C Traversari, ... Human gene therapy 6 (6), 813-819, 1995 | 188 | 1995 |